Status:
NOT_YET_RECRUITING
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Rhabdomyosarcoma
Eligibility:
All Genders
18+ years
Brief Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with rhabdomyosarcoma who partake in a separate clinical trial featuring a specific medical intervention. The primary emph...
Eligibility Criteria
Inclusion
- Diagnosis of rhabdomyosarcoma
- Considered reliable, able to understand, and willing to perform all study procedures
- Signed Written Informed Consent
Exclusion
- Currently enrolled in, have completed or have discontinued from a clinical trial involving an investigational drug
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Any serious and/or unstable pre-existing medical disorders
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06029465
Start Date
October 1 2024
End Date
October 1 2026
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107